Kiniksa Pharmaceuticals International Plc (KNSA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 183,581 | 107,954 | 122,715 | 122,470 | 114,248 |
| Marketable Securities | 60,046 | 98,417 | 67,893 | 59,731 | 209,444 |
| Receivables | 41,724 | 21,266 | 12,660 | 3,985 | N/A |
| Inventories | 26,364 | 31,122 | 21,599 | 3,675 | N/A |
| Other current assets | 0 | 0 | 7,656 | 0 | 0 |
| TOTAL | $331,799 | $276,297 | $243,060 | $196,446 | $333,249 |
| Non-Current Assets | |||||
| PPE Net | 662 | 734 | 1,658 | 2,834 | 4,051 |
| Intangibles | 16,250 | 17,250 | 18,250 | 19,250 | 0 |
| Other Non-Current Assets | 231,842 | 232,041 | 196,704 | 14,270 | 12,164 |
| TOTAL | $248,754 | $250,025 | $216,612 | $36,354 | $16,215 |
| Total Assets | $580,553 | $526,322 | $459,672 | $232,800 | $349,464 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,039 | 8,246 | 7,899 | 1,868 | 503 |
| Accrued Expenses | 80,512 | 44,667 | 30,112 | 38,031 | 29,199 |
| Other current liabilities | 16,077 | 8,193 | 5,754 | 1,544 | 37 |
| TOTAL | $100,621 | $63,666 | $47,066 | $44,824 | $31,846 |
| Non-Current Liabilities | |||||
| Deferred Revenues | N/A | 307 | N/A | N/A | N/A |
| Other Non-Current Liabilities | 9,685 | 11,863 | 4,457 | 2,939 | 5,683 |
| TOTAL | $41,496 | $23,817 | $16,457 | $2,939 | $5,683 |
| Total Liabilities | $142,117 | $87,483 | $63,523 | $47,763 | $37,529 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 72,644 | 70,615 | 69,753 | 69,104 | 68,232 |
| Common Shares | 20 | 20 | 19 | 18 | 18 |
| Retained earnings | -521,143 | -477,950 | -492,034 | -675,397 | -517,473 |
| Other shareholders' equity | -163 | 6 | 44 | -66 | -34 |
| TOTAL | $438,436 | $438,839 | $396,149 | $185,037 | $311,935 |
| Total Liabilities And Equity | $580,553 | $526,322 | $459,672 | $232,800 | $349,464 |